SOL Global Investments Corp. SOL

Company Overview

SOL Global Investments Corp. is a publicly traded Canadian investment company focused on providing capital, strategic support, and operational expertise to companies primarily in the cannabis, life sciences, and consumer packaged goods sectors. The company operates as an investment holding and merchant banking platform, seeking minority and controlling interests in businesses where it believes active involvement can enhance value creation. Its revenue and asset value are primarily driven by investment performance, asset appreciation, and, to a lesser extent, management and advisory activities associated with its portfolio companies.

Originally incorporated as Scythian Biosciences Corp. in 2014, the company initially pursued opportunities in pharmaceutical cannabinoids and plant-based therapeutics. Following strategic and leadership changes, it rebranded to SOL Global Investments Corp. in 2019 to reflect a broader investment mandate beyond pure biotechnology. Since then, SOL has evolved into a diversified investment vehicle with a strong emphasis on cannabis-related assets, particularly in the United States, positioning itself as an early-stage and growth-focused investor in regulated markets.